首页> 外文期刊>Life sciences >Vildagliptin, a dipeptidyl peptidase-4 inhibitor, reduces betel-nut induced carcinogenesis in female mice
【24h】

Vildagliptin, a dipeptidyl peptidase-4 inhibitor, reduces betel-nut induced carcinogenesis in female mice

机译:二肽基肽酶-4抑制剂vildagliptin,减少了雌性小鼠的Betel-nut诱发的致癌物

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: Betel-nut, a popular masticatory among Southeast Asian populations is a class I carcinogen, previously associated with dyslipidemia and aberrant lipid metabolism, and is reported to be used more frequently by females, than males. This study investigates the potential of repurposing the anti-diabetic drug, vildagliptin, a dipeptidyl peptidase-4 inhibitor, for alleviating the oncogenic condition in female Swiss Albino mice administered an aqueous extract of betel-nut (AEBN) orally (2 mg ml(-1)) for 24 weeks.
机译:目的:槟榔是东南亚人群中流行的咀嚼品,是一种I类致癌物,以前与血脂异常和脂质代谢异常有关,据报道,女性比男性更频繁地使用槟榔。这项研究调查了抗糖尿病药物vildagliptin(二肽基肽酶-4抑制剂)的潜在用途,以减轻口服槟榔水提取物(AEBN)24周的雌性瑞士白化小鼠的致癌状况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号